Cite
Prognostic value of primary tumor volume after concurrent chemoradiation with daily low-dose cisplatin for advanced-stage head and neck carcinoma.
MLA
Hoebers, Frank J. P., et al. “Prognostic Value of Primary Tumor Volume after Concurrent Chemoradiation with Daily Low-Dose Cisplatin for Advanced-Stage Head and Neck Carcinoma.” Head & Neck, vol. 30, no. 9, Sept. 2008, pp. 1216–23. EBSCOhost, https://doi.org/10.1002/hed.20865.
APA
Hoebers, F. J. P., Pameijer, F. A., de Bois, J., Heemsbergen, W., Balm, A. J. M., Schornagel, J. H., & Rasch, C. R. N. (2008). Prognostic value of primary tumor volume after concurrent chemoradiation with daily low-dose cisplatin for advanced-stage head and neck carcinoma. Head & Neck, 30(9), 1216–1223. https://doi.org/10.1002/hed.20865
Chicago
Hoebers, Frank J P, Frank A Pameijer, Josien de Bois, Wilma Heemsbergen, Alfons J M Balm, Jan H Schornagel, and Coen R N Rasch. 2008. “Prognostic Value of Primary Tumor Volume after Concurrent Chemoradiation with Daily Low-Dose Cisplatin for Advanced-Stage Head and Neck Carcinoma.” Head & Neck 30 (9): 1216–23. doi:10.1002/hed.20865.